FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

@inproceedings{Griffiths2009FRAGMATICAR,
  title={FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer},
  author={Gareth Griffiths and Sarah Burns and Simon Noble and Fergus R Macbeth and David R. Cohen and Timothy S. Maughan},
  booktitle={BMC Cancer},
  year={2009}
}
Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE is common in patients with cancer and is increased by surgery, chemotherapy, radiotherapy and disease progression. Low molecular weight heparin (LMWH) is routinely used to treat VTE and some evidence suggests that LMWH may also have an anticancer effect, by reduction in the… CONTINUE READING